Structured Contraceptive Counseling During Pregnancy
Evaluating Effects of Prepartum Structured Contraceptive Counseling to Increase Postpartum Use of Long-acting Reversible Contraception
1 other identifier
interventional
160
1 country
4
Brief Summary
Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between 12-24 months from childbirth. This is a prospective observational intervention study, aiming to evaluate the effects of structured contraceptive counseling during pregnancy on uptake of contraception postpartum and more specifically on long-acting reversible contraceptive methods, and to identify and explore the provider's and patient's experiences of structured contraceptive counseling during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedStudy Start
First participant enrolled
November 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedSeptember 10, 2025
September 1, 2025
2.6 years
September 15, 2022
September 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in proportions of LARC use 6 months postpartum among women receiving structured contraceptive counseling compared to standard care during pregnancy.
Percentage
6 months post partum
Secondary Outcomes (2)
New pregnancy
6, 12, 18, and 24 months postpartum
Outcome of new pregnancy
6, 12, 18, nd 24 months postpartum
Study Arms (1)
Intervention arm
EXPERIMENTALEvidence-based intervention for SCC, previously evaluated in a cluster randomized trial (doi:10.1111/1471-0528.16754) The intervention for prepartum SCC will consist of four different parts, adjusted to suit pregnant women with emphasis on immediate start when applicable: 1. An educational video presenting available contraceptive methods 2. 4 Key questions concerning how to deal with a new pregnancy, reproductive life plan, and additional health benefits from using contraception. 3. A tiered effectiveness chart of available contraceptives 4. A box of contraceptive models
Interventions
1. Educational video - healthcare providers (Medical doctors and nurse-midwives)present available contraceptives that could be used after delivery, with emphasis on effectiveness, how they should be used, mechanism of action and health benefits. 2. The four key questions are to be asked to all pregnant women to make them reflect on factors that highly affects choice of contraceptives. 3. A tiered effectiveness chart will be used to visualize the effectiveness of different contraceptives, and guide the prospective user in her choice depending on the answers to the key questions 4. The box of contraceptive models are used for the prospective user to inspect, hold, feel the different contraceptives, as this has been shown to decrease fear regarding specific methods.
Eligibility Criteria
You may qualify if:
- years or older, gestational week 30 or more, need for contraception 6 months or more after delivery
You may not qualify if:
- \- Language barrier that affects participation when an interpreter is not available, assisted fertilization, planned sterilization of partner, use of contraception for other purposes than pregnancy prevention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Health Care Region Dalarna
Falun, Sweden
Health Care Region Värmland
Karlstad, Sweden
Health Care Region Örebro Län
Örebro, Sweden
Health Care Region Uppsala
Uppsala, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Niklas Envall, PhD
Dalarna University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, RNM, Senior Lecturer
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 22, 2022
Study Start
November 19, 2022
Primary Completion
June 19, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
September 10, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
Upon request, de-identified data might be shared with other researchers that share the purpose of this trial